Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016380032> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2016380032 endingPage "659" @default.
- W2016380032 startingPage "658" @default.
- W2016380032 abstract "Though the introduction of office-based buprenorphine has greatly contributed to stem the HIV epidemic since 1995, concerns have been raised about the intravenous use of buprenorphine even in patients on substitution treatment. The aim of this study was to identify which factors are predictive of buprenorphine injection in patients receiving office-based buprenorphine.Subazur is a survey consisting of two longitudinal assessments of 111 stabilized patients receiving office-based buprenorphine in southeastern France.Patients were interviewed by phone at enrolment and 6 months later about social characteristics, addictive behaviors, treatment experiences, overdoses and suicide ideation or attempt. A logistic regression based on generalized estimating equations (GEE) was used to identify factors associated with buprenorphine injection at any interview.Among the 111 patients (32% women, mean age 38 years), 36 reported buprenorphine injection after having started treatment initiation in 40 interviews. After adjustment for time since first injection, individuals perceiving their prescribed dosage as inadequate (OR = 2.6 95%CI[1.2–5.7]) and those reporting a history of suicide ideation or attempt (OR = 2.7 95%CI[1.1–7.0]) had approximately a three-fold higher risk of injecting buprenorphine.Providing adequate care for both drug dependence and psychiatric comorbidities in primary care is a major issue. Like heroin use during methadone treatment, buprenorphine injection should be regarded more as a response to inadequate care than simply as a “misuse”. A re-assessment of the treatment efficacy through a possible dosage increase or a switch to methadone could potentially reduce diversion and assure sustained adherence to OST." @default.
- W2016380032 created "2016-06-24" @default.
- W2016380032 creator A5036506208 @default.
- W2016380032 creator A5042563185 @default.
- W2016380032 creator A5067761396 @default.
- W2016380032 creator A5069176084 @default.
- W2016380032 creator A5089944449 @default.
- W2016380032 date "2004-06-01" @default.
- W2016380032 modified "2023-10-18" @default.
- W2016380032 title "Pancréatite aiguë associée à l'injection intraveineuse de buprénorphine chez une toxicomane" @default.
- W2016380032 cites W2003972989 @default.
- W2016380032 cites W2059346487 @default.
- W2016380032 cites W2080878859 @default.
- W2016380032 doi "https://doi.org/10.1016/j.annfar.2004.03.006" @default.
- W2016380032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15234740" @default.
- W2016380032 hasPublicationYear "2004" @default.
- W2016380032 type Work @default.
- W2016380032 sameAs 2016380032 @default.
- W2016380032 citedByCount "7" @default.
- W2016380032 countsByYear W20163800322022 @default.
- W2016380032 crossrefType "journal-article" @default.
- W2016380032 hasAuthorship W2016380032A5036506208 @default.
- W2016380032 hasAuthorship W2016380032A5042563185 @default.
- W2016380032 hasAuthorship W2016380032A5067761396 @default.
- W2016380032 hasAuthorship W2016380032A5069176084 @default.
- W2016380032 hasAuthorship W2016380032A5089944449 @default.
- W2016380032 hasConcept C105795698 @default.
- W2016380032 hasConcept C118552586 @default.
- W2016380032 hasConcept C126322002 @default.
- W2016380032 hasConcept C151956035 @default.
- W2016380032 hasConcept C170493617 @default.
- W2016380032 hasConcept C194828623 @default.
- W2016380032 hasConcept C27403532 @default.
- W2016380032 hasConcept C2778767360 @default.
- W2016380032 hasConcept C2778903686 @default.
- W2016380032 hasConcept C2778949969 @default.
- W2016380032 hasConcept C2780035454 @default.
- W2016380032 hasConcept C2781063702 @default.
- W2016380032 hasConcept C33923547 @default.
- W2016380032 hasConcept C42219234 @default.
- W2016380032 hasConcept C53084192 @default.
- W2016380032 hasConcept C71924100 @default.
- W2016380032 hasConceptScore W2016380032C105795698 @default.
- W2016380032 hasConceptScore W2016380032C118552586 @default.
- W2016380032 hasConceptScore W2016380032C126322002 @default.
- W2016380032 hasConceptScore W2016380032C151956035 @default.
- W2016380032 hasConceptScore W2016380032C170493617 @default.
- W2016380032 hasConceptScore W2016380032C194828623 @default.
- W2016380032 hasConceptScore W2016380032C27403532 @default.
- W2016380032 hasConceptScore W2016380032C2778767360 @default.
- W2016380032 hasConceptScore W2016380032C2778903686 @default.
- W2016380032 hasConceptScore W2016380032C2778949969 @default.
- W2016380032 hasConceptScore W2016380032C2780035454 @default.
- W2016380032 hasConceptScore W2016380032C2781063702 @default.
- W2016380032 hasConceptScore W2016380032C33923547 @default.
- W2016380032 hasConceptScore W2016380032C42219234 @default.
- W2016380032 hasConceptScore W2016380032C53084192 @default.
- W2016380032 hasConceptScore W2016380032C71924100 @default.
- W2016380032 hasIssue "6" @default.
- W2016380032 hasLocation W20163800321 @default.
- W2016380032 hasLocation W20163800322 @default.
- W2016380032 hasOpenAccess W2016380032 @default.
- W2016380032 hasPrimaryLocation W20163800321 @default.
- W2016380032 hasRelatedWork W1922618916 @default.
- W2016380032 hasRelatedWork W2032713247 @default.
- W2016380032 hasRelatedWork W2051120139 @default.
- W2016380032 hasRelatedWork W2052229568 @default.
- W2016380032 hasRelatedWork W2060726569 @default.
- W2016380032 hasRelatedWork W2080598760 @default.
- W2016380032 hasRelatedWork W2085981430 @default.
- W2016380032 hasRelatedWork W2159009281 @default.
- W2016380032 hasRelatedWork W2168900440 @default.
- W2016380032 hasRelatedWork W2920590001 @default.
- W2016380032 hasVolume "23" @default.
- W2016380032 isParatext "false" @default.
- W2016380032 isRetracted "false" @default.
- W2016380032 magId "2016380032" @default.
- W2016380032 workType "article" @default.